CD9: A possible clue into breast cancer chemoresistance
CD9: A possible clue into breast cancer chemoresistance |
|
https://doi.org/10.18632/oncotarget.27130
Natalia Pacienza,
and Gustavo Yannarelli
|
| 4921-4922 |
V-ATPase-associated prorenin receptor is upregulated in prostate cancer after PTEN loss
V-ATPase-associated prorenin receptor is upregulated in prostate cancer after PTEN loss |
|
https://doi.org/10.18632/oncotarget.27075
Amro H. Mohammad,
Sarah Assadian,
Frédéric Couture,
Karen J. Lefebvre,
Wissal El-Assaad,
Veronique Barrès,
Veronique Ouellet,
Pierre-Luc Boulay,
Jieyi Yang,
Mathieu Latour,
Luc Furic,
William Muller,
Nahum Sonenberg,
Anne-Marie Mes-Masson,
Fred Saad,
Robert Day,
and Jose G. Teodoro
|
| 4923-4936 |
ALK mutation dynamics and clonal evolution in a neuroblastoma model exhibiting two ALK mutations
ALK mutation dynamics and clonal evolution in a neuroblastoma model exhibiting two ALK mutations |
|
https://doi.org/10.18632/oncotarget.27119
Simon Durand,
Cécile Pierre-Eugène,
Olivier Mirabeau,
Caroline Louis-Brennetot,
Valérie Combaret,
Léo Colmet-Daage,
Orphée Blanchard,
Angela Bellini,
Estelle Daudigeos-Dubus,
Virginie Raynal,
Gudrun Schleiermacher,
Sylvain Baulande,
Olivier Delattre,
and Isabelle Janoueix-Lerosey
|
| 4937-4950 |
PTEN interacts with RNA polymerase II to dephosphorylate polymerase II C-terminal domain
PTEN interacts with RNA polymerase II to dephosphorylate polymerase II C-terminal domain |
|
https://doi.org/10.18632/oncotarget.27128
Ata Abbas,
Todd Romigh,
and Charis Eng
|
| 4951-4959 |
Inactivation of beta1 integrin induces proteasomal degradation of Myc oncoproteins
Inactivation of beta1 integrin induces proteasomal degradation of Myc oncoproteins |
|
https://doi.org/10.18632/oncotarget.27131
Manabu Sasada,
Takuya Iyoda,
Tatsufumi Asayama,
Yusuke Suenaga,
Shunsuke Sakai,
Naoya Kase,
Hiroaki Kodama,
Sana Yokoi,
Yoichiro Isohama,
and Fumio Fukai
|
| 4960-4972 |
Nuclear ELAC2 overexpression is associated with increased hazard for relapse after radical prostatectomy
Nuclear ELAC2 overexpression is associated with increased hazard for relapse after radical prostatectomy |
|
https://doi.org/10.18632/oncotarget.27132
Cornelia Schroeder,
Elham Navid-Hill,
Jan Meiners,
Claudia Hube-Magg,
Martina Kluth,
Georgia Makrypidi-Fraune,
Ronald Simon,
Franziska Büscheck,
Andreas M. Luebke,
Cosima Goebel,
Dagmar S. Lang,
Sören Weidemann,
Emily Neubauer,
Andrea Hinsch,
Frank Jacobsen,
Patrick Lebok,
Uwe Michl,
Dirk Pehrke,
Hartwig Huland,
Markus Graefen,
Thorsten Schlomm,
Guido Sauter,
and Doris Höflmayer
|
| 4973-4986 |
Methylation alteration of SHANK1 as a predictive, diagnostic and prognostic biomarker for chronic lymphocytic leukemia
Methylation alteration of SHANK1 as a predictive, diagnostic and prognostic biomarker for chronic lymphocytic leukemia |
|
https://doi.org/10.18632/oncotarget.27080
Eleonora Loi,
Loredana Moi,
Antonio Fadda,
Giannina Satta,
Mariagrazia Zucca,
Sonia Sanna,
Shadi Amini Nia,
Giuseppina Cabras,
Marina Padoan,
Corrado Magnani,
Lucia Miligi,
Sara Piro,
Davide Gentilini,
Maria Grazia Ennas,
Melissa C. Southey,
Graham G. Giles,
Nicole Wong Doo,
Pierluigi Cocco,
and Patrizia Zavattari
|
| 4987-5002 |
Correction: By promoting cell differentiation, miR-100 sensitizes basal-like breast cancer stem cells to hormonal therapy
Correction: By promoting cell differentiation, miR-100 sensitizes basal-like breast cancer stem cells to hormonal therapy |
|
https://doi.org/10.18632/oncotarget.27151
Annalisa Petrelli,
Rosachiara Carollo,
Marilisa Cargnelutti,
Flora Iovino,
Maurizio Callari,
Daniela Cimino,
Matilde Todaro,
Laura Rosa Mangiapane,
Alessandro Giammona,
Adriana Cordova,
Filippo Montemurro,
Daniela Taverna,
Maria Grazia Daidone,
Giorgio Stassi,
and Silvia Giordano
|
| 5003-5004 |
